L'Institut Pasteur. For over 125 years, Institut Pasteur has been at the forefront of basic and biomedical research. Exploring the formation of distinct memories, Health and environment: Institut Pasteur and AFD commit to a new program, Hepatitis B may infect twice more African babies than HIV, Hepatitis B: natural controllers shed light on immunity mechanisms, Hepatitis B: new guidelines for treating HBV-positive pregnant women, High-level microscopy unveils bacteria’s adaptation mechanisms, How Chlamydia trachomatis hijacks energy stores from its host, How Helicobacter pylori survives gastric acidity, How Listeria monocytogenes blocks intestinal villus invasion. Institut Pasteur Lille sounds like a public research institute to French people, but it’s actually not. Tour d'horizon des stratégies vaccinales de la Fondation. Anna-Bella Failloux, an all-terrain entomologist! Dear Friends of the Pasteur Foundation US. 15 Service de Maladies Infectieuses et Tropicales, Hôpital Bichat - Claude-Bernard, Paris, France. The Georges, Jacques and Elias Canetti Prize celebrates its 15th anniversary! Institute Pasteur Global Network & the Fight against Emerging Infections (Dr. M. Jouan, Institut Pasteur) ... And more and more these institutes are mobilized also on this particular field, new area of action. Advancing Global Health Since 1891Explore the Network », 10 Nobel Prizes have been awarded to Pasteur ScientistsDiscover Why », PASTEUR FOUNDATION420 Lexington Avenue, Suite 1654, New York, NY, 10170 | Tel: 212-599-2050 |  Fax: 212-599-2047 |  Email: director@pasteurfoundation.org, The Pasteur Foundation is a registered 501(c)3 Organization. It’s supposed to be a private foundation. “The Geopolitics of the Mosquito” - Go further with our experts! With its new "Omics" buildings, the Institut Pasteur continues its digital revolution, Yellow fever: a new method for testing vaccine safety, Zika: an accurate estimation of the neurological risks in unborn children, Zika: silent long-term circulation in Thailand, All SARS-CoV-2 / COVID-19 from the Institut Pasteur, A SARS-CoV-2 genome sequencing technique to analyze low-quality clinical samples, A combination of cutting-edge proteomic approaches for improving understanding of SARS-CoV-2 infection mechanisms, A technique to identify key cellular factors for SARS-CoV-2 infection, A zebrafish model to study SARS-CoV-2 neuroinvasion, Accelerating the identification & design of SARS-CoV2 antiviral drugs in combination with the “DrugDesign_SARS2” project, Antibody profiling in recovering patients and development of a serological test for an epidemiological survey in individuals exposed to SARS-CoV-2, Building a collection of human biological samples in France, Characterization of interaction between SARS-CoV-2 Nsp3 protein and non-canonical nucleic acid structures (G4) present in infected cells, Characterization of variable systemic and mucosal immunity during SARS-CoV-2 infection and recovery, Covid-19 risk evaluation among the household contacts of the first cases in Africa, Covid-19: A vaccine candidate using a lentiviral vector, Covid-19: vaccine against SARS-CoV-2 infection, using the measles vector, Deciphering the virus interactions with the entry receptors in human cells, and their potential inhibition, Defective viral genomes (DVGs), potential antiviral inhibitors of SARS-CoV-2, Descriptive study: epidemiological, clinical and immunological analysis of SARS-CoV-2 cases in the Metropolitan Region of São Paulo, Brazil, Developing a rapid diagnostic test to detect SARS-CoV2 virus in various environment, Development of an animal model and accelerated development of a DNA vaccine candidate, Development of novel nano-based multi-epitope vaccine against coronavirus SARS-CoV-2 - Generation of Humanized NSG transfer mouse model for vaccine testingAim: We hypothesize that it may be possible to generate protective anti-SARS-CoV-2 immuneresponse in, Development of simple Covid-19 serological tools and targeted serosurvey of at-risk individuals, Drug Repurposing & Design to inhibit the SARS-CoV2 proteases, Engineering an ACE2 derived polypeptide for label-free, real-time detection on a smartphone device and therapeutic intervention, Evaluating the determinants of coronavirus tropism in 3D models of human pulmonary epithelia, Evaluation of SARS-CoV-2 infection spread in various populations groups in Cameroon, Evaluation of clinical presentation and evolution of SARS -CoV-2 coronavirus infection in Senegal, Evolution of SARS-CoV-2 and the antibody immune response in humans during infection, Find potent antiviral drugs against SARS-CoV2 by targeting well identified proteins essential to the viral cycle, Generation of animal models sensitive to SARS-CoV-2 to test vaccines or drugs, Household transmission investigation study for SARS in overseas territories, Identification and isolation of potent human neutralizing antibodies against SARS-CoV-2, Identification of cellular PDZ-containing Proteins targeted by the virus SARS-Cov-2 during infection, Investigating the role of apico-basal proteins during SARS-Cov2 infection, Investigation of the first cases of coronavirus (COVID-19) infections and their contacts in Antananarivo, Madagascar, Isolating and characterizing the human antibodies that neutralize SARS-CoV-2, Mechanisms of intercellular spreading of SARS-CoV-2: assessing the role of TNTs to escape immune surveillance and expand tropism and pathogenicity, Modeling human SARS-CoV-2 infection in mice with human lung xenografts, Monitoring the origins and transmission/spread of SARS-CoV-2 in Laos and Vietnam: searching for SARS-like viruses and detecting antibodies in vertebrates, Neurological implications of SARS-COV-2 infection – a transversal study, Nicotinic modulation of SARS-CoV-2 infection in the brain, Origins, natural reservoirs and interspecies transmission of SARS-CoV-2 and other SARS-like coronaviruses, Production of recombinant antigens from two SARS-CoV-2 proteins and generation of nano-antibodies against these proteins for diagnostic and therapeutic applications, Profiling SARS-CoV-2 intra-viral and virus-host interactions on the basis of innate immunity signaling, Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting, Randomized trial of Covid-19 chemoprophylaxis in healthcare professionals, Red Cross health workers and volunteers and continuity of care with COVID-19: an operational approach using mixed methods, Restriction of SARS-CoV-2 replication by coding and non-coding genes, SARS-CoV-2 fusion, replication and host responses, Sequence the complete genome of Covid-19 directly and at low cost from prepared RNA samples from patients, Serological surveillance of SARS-CoV-2 and seasonal coronaviruses, Short Amplicon Based Sequencing Of SARS-CoV-2 for low-input samples, Spike glycoprotein, lentiviral vectors and B/T-cell vaccine, The use of Artificial Intelligence Methods to Discriminate Covid-19 from other Community Acquired Pneumopathy using Chest X-Ray and CT images, Urgent Discovery of Drug Candidates That Target Coronavirus SARS-CoV-2, Working towards controlled detection of SARS-CoV-2 by the innate immune system, rBCG vaccine secreting SARS-CoV-2 antigens, Global Health at the Human-Animal-Ecosystem Interface, MOOC Concepts and Methods in Epidemiology - Institut Pasteur/Cnam, MOOC Diagnosis and prognosis biomarkers in global health - Institut Pasteur, MOOC In the footsteps of Zika… approaching the unknown​, Mooc From neuron to behavior - Institut Pasteur/Cnam, The Institut Pasteur Online Diploma of Infectious Diseases (DNM2IP), Erasmus+ University of Szeged, Faculty of Medicine, University of Szeged, Faculty of Medicine, Pasteur-Paris University International doctoral program​ (PPU), 4-year research group within the Scientific Platform Pasteur-University of Sao Paulo, Groupes à 4 ans à l'Institut Pasteur de Shanghai - Académie des Sciences de Chine, Cité Internationale Universitaire de Paris, MOOC Medical entomology - Insect vectors and transmission of pathogens, New Edition Of The Free On-Line Mooc Malaria, New Edition Of The Free On-Line Mooc Tuberculosis, New Free On-Line Course Created By Institut Pasteur: Clinical Trials In Infectious And TropicalL Diseases, Registration for Pasteur/Cnam School of Public Health, Registration open for the Institut Pasteur neuroscience MOOC​, Pasteur International Network association, 1st workshop on Translational Venomic Medecine, Infectious diseases pathogenesis in Asia/Pacific, Insects and vector-borne diseases in Amazonia and the Caribbean: from field to lab, Methodology of Clinical Trials and Practical Implementation, Persistent Viral Infections and Immune evasion, Workshop on Surveillance and Control of Rabies, Centre de ressources biologiques de l’Institut Pasteur (CRBIP), Clinical Investigation and Access to BioResources (ICAReB), Collection Nationale de Cultures de Microorganismes (CNCM), Detection, Financing of Innovation and Entrepreneurship Office, Industrial Agreements - Post Contract and Strategic Alliance, Technology Transfer and Industrial Partnership, Business development and technology transfer. In a year filled with extraordinary challenges and devastation, good news seems hard to come by. google: { families: [ 'Gilda+Display::latin', 'Gudea:400,700,400italic:latin', 'Quattrocento:400,700:latin' ] } 16 Control de Epidemia Desastres y Otras Emergencias Sanitarias, Oficina General de … Notre histoire. The Pasteur Institute was a product of Louis Pasteur’s victory over rabies; for vaccination against rabies represented just that for the entire world. For over 125 years, Institut Pasteur has been at the forefront of basic and biomedical research. Yellow fever, the story of a re-emerging virus. ©Institut Pasteur Au cœur de sa mission de recherche, une des ambitions de l’Institut est de combattre la résistance aux antibiotiques . Please take great pride in knowing that your efforts, your commitment, and your ongoing financial support, has and continues to inspire scientists like Professor Charpentier -- our 11th Nobel Laureate! This RIIP Database is accessible to all scientific and institutional partners by institutions, scientific staff, projects, thematics and key words. The first five departments were directed by two normaliens (graduates of the École Normale Supérieure), Émile Duclaux (general microbiology research) and Charles Chamberland (microbes research applied to hygiene), a biologist, Ilya Ilyich Mechn… Dans le cadre du Plan Cancer III 2014-2019, et l’Institut thématique multiorganisme santé publique de l’Alliance nationale pour les sciences de la vie et de la santé (Aviesan) en collaboration avec l’Institut de echeche en santé publi ue (IReSP) sont responsables de la sous-action 1.2.5. L'Institut Pasteur de Paris est composé de 100 unités de recherche et de près de 2 700 personnes. Additionally, information on this page will keep you further informed and engaged. [CDATA[ Researchers from Hong-Kong University - Pasteur Research Pole and Institut Pasteur of New Caledonia are winners of the "Pasteur Network Talent Award" 2020. The Research Journal : the most read articles in 2017! The Pasteur Foundation US Board of Directors, PS: Want to fund the next generation of Nobel Prize winning Pasteurians? Ses chercheurs travaillent sur trois pistes, dont l'une a déjà été testée sur l'homme. // ]]]]>